SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-24-024968
Filing Date
2024-03-04
Accepted
2024-03-04 17:25:26
Documents
1
Period of Report
2024-03-01

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 5907
  Complete submission text file 0000950170-24-024968.txt   7507
Mailing Address 10 EARLSFORT TERRACE DUBLIN 2 L2 D02 T380
Business Address 10 EARLSFORT TERRACE DUBLIN 2 L2 D02 T380 353 1 905 8020
Mural Oncology plc (Issuer) CIK: 0001971543 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address MURAL ONCOLOGY LTD. 10 EARLSFORT TERRACE DUBLIN 2 L2 D02 T380
Business Address
Loew Caroline (Reporting) CIK: 0001989488 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-41837 | Film No.: 24716083